Spastic cerebral palsy. Spastic diplegic cerebral palsy
Conditions
Interventions
Intervention 1: Intervention Group 1 (Occupational-Based Group with MIT): Participants in this group will attend a total of 23 sessions. The first session will consist of a data collection session, in
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: a diagnosis of spastic CP and no other neurological disorders upon self-declaration of participant having the age of more than 18 years the ability to stand and walk either with or without assistance Not having severe depression the ability to communicate discomfort or pain the comprehension of simple instructions of the tasks during intervention and data collection sessions
Exclusion criteria
Exclusion criteria: Any contraindications to participating in the training sessions botulinum toxin (BoTox) injections within six months before the assessment the presence of an intrathecal baclofen pump or any surgical intervention in the past 12 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional mobility. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: Functional mobility will be assessed through Timed Up and Go (TUG) test to evaluate a person's mobility, balance, walking ability, and fall risk. lower score in this test indicates better performance in movement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional balance. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: Berg Balance Scale (BBS).;Quality of life. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: World Health Organization Quality of Life questionnaire- Brief version.;Gait parameters. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: measuring speed, step length, and step width during walking.;Motor imagery ability. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: Chronometer test, and Laterality test.;Anxiety level. Timepoint: Baseline, post-intervention (month 2), and follow-up (month 2). Method of measurement: Anxiety subscale of Hospital and Depression Scale (HADS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhorban Taghizadeh
Iran University of Medical Sciences
Outcome results
None listed